A prospective study of genital herpes simplex virus type 2 infection in human immunodeficiency virus type 1 (HIV-1)-seropositive women: Correlations with CD4 cell count and plasma HIV-1 RNA level

Clinical Infectious Diseases

Volumn 36, Issue 2, 2003, Pages 207-211

  Wright, Patty W ^b   Hoesley, Craig J ^c   Squires, Kathleen E ^a   Croom Rivers, Angela ^d   Weiss, Heidi L ^d   Gnann Jr , John W ^d  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; CD4 ANTIGEN; CIDOFOVIR; RNA; VALACICLOVIR;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL FEATURE; CORRELATION ANALYSIS; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; FEMALE; GENITAL HERPES; GENITAL SYSTEM; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; NONHUMAN; OUTPATIENT; PELVIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROLOGY; SYMPTOM; UTERINE CERVIX CYTOLOGY;

ADULT; AGED; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; FEMALE; GENITAL DISEASES, FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; RNA, VIRAL;

EID: 0037439511     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/345440     Document Type: Article

References (14)

1. Fleming DT, McQuillan GM, lohnson RE, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997; 337:1105-11.
2. Centers for Disease Control and Prevention. HIV AIDS Surveil Rep 1999; 11:1-42.
3. Augenbraun M, Feldman J, Chirgwin K, et al. Increased genital shedding of herpes simplex type 2 in HIV-1-seropositive women. Ann Intern Med 1995; 123:845-7.
4. Schaker T, Ryncarz A, Goddard J, et al. Frequent recovery of HIV-1 from genital herpes simplex lesions in HIV-1-infected men. JAMA 1998; 280:61-6.
5. Kreiss JK, Coombs R, Plummer F, et al. Isolation of human immunodeficiency virus from genital ulcers in Nairobi prostitutes. J Infect Dis 1989; 160:380-4.
6. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis 2002; 185:45-52.
7. Augenbraun M, Corey L, Reichelderfer P, et al. Herpes simplex virus shedding and plasma human immunodeficiency virus levels in coinfected women. Clin Infect Dis 2001; 33:885-90.
8. Brock B, Selke S, Benedetti J, et al. Frequency of asymptomatic shedding of herpes simplex virus in women with genital herpes. JAMA 1990; 263:418-20.
9. Wald A, Zeh J, Selke S, et al. Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med 1995; 333:770-5.
10. Wald A, Zeh J, Selke S, et al. Reactivation of genital herpes simplex type 2 infections in asymptomatic seropositive persons. N Engl J Med 2000; 342:844-50.
11. Mbopi-Keou FX, Gresenguet G, Mayaud P, et al. Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in African women: opportunities for intervention. J Infect Dis 2000; 182:1090-6.
12. Stewart JA, Reef SE, Pellett PE, et al. Herpesvirus infections in persons infected with human immunodeficiency virus. Clin Infect Dis 1995; 21(Suppl 1):S114-20.
13. Quinnan GV Jr, Masur H, Rook AH, et al. Herpes virus infections in the acquired immunodeficiency syndrome. JAMA 1984; 252:72-7.
14. Safrin S, Ashley R, Houlihan C, et al. Clinical and serologic features of herpes simplex virus infection in patients with AIDS. AIDS 1991; 5:1107-10.